Cargando…

The Post-Antibiotic Era: A New Dawn for Bacteriophages

SIMPLE SUMMARY: Phages, also known as bacteriophages, are bacteria-specific viruses that are ushering in a new dawn following the increase in antibiotic resistance. In nature, phages are distributed wherever bacteria exist. They are divided into lytic and lysogenic phages based on their reproduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Youshun, Li, Wei, Zhang, Huaiyu, Ba, Xuli, Li, Zhaocai, Zhou, Jizhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215799/
https://www.ncbi.nlm.nih.gov/pubmed/37237494
http://dx.doi.org/10.3390/biology12050681
_version_ 1785048149400748032
author Jin, Youshun
Li, Wei
Zhang, Huaiyu
Ba, Xuli
Li, Zhaocai
Zhou, Jizhang
author_facet Jin, Youshun
Li, Wei
Zhang, Huaiyu
Ba, Xuli
Li, Zhaocai
Zhou, Jizhang
author_sort Jin, Youshun
collection PubMed
description SIMPLE SUMMARY: Phages, also known as bacteriophages, are bacteria-specific viruses that are ushering in a new dawn following the increase in antibiotic resistance. In nature, phages are distributed wherever bacteria exist. They are divided into lytic and lysogenic phages based on their reproduction. Specifically, lysogenic phages reproduce within the bacteria as genetic elements, while lytic phages directly lyse bacteria to release progeny phages. Therefore, lytic phages can be used to treat bacterial infections. However, because the current phage therapy (PT) system has not yet been streamlined, there are still a series of PT-related concerns, such as phage isolation and purification efficiency, the immune response induced by PT, and the impact on intestinal microorganisms. Therefore, synthetic biology, bioinformatics, and artificial intelligence should be combined to edit high-efficiency directionally engineered phages that are safe for humans while effectively killing drug-resistant bacteria. ABSTRACT: Phages are the most biologically diverse entities in the biosphere, infecting specific bacteria. Lytic phages quickly kill bacteria, while lysogenic phages integrate their genomes into bacteria and reproduce within the bacteria, participating in the evolution of natural populations. Thus, lytic phages are used to treat bacterial infections. However, due to the huge virus invasion, bacteria have also evolved a special immune mechanism (CRISPR-Cas systems, discovered in 1987). Therefore, it is necessary to develop phage cocktails and synthetic biology methods to infect bacteria, especially against multidrug-resistant bacteria infections, which are a major global threat. This review outlines the discovery and classification of phages and the associated achievements in the past century. The main applications of phages, including synthetic biology and PT, are also discussed, in addition to the effects of PT on immunity, intestinal microbes, and potential safety concerns. In the future, combining bioinformatics, synthetic biology, and classic phage research will be the way to deepen our understanding of phages. Overall, whether phages are an important element of the ecosystem or a carrier that mediates synthetic biology, they will greatly promote the progress of human society.
format Online
Article
Text
id pubmed-10215799
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102157992023-05-27 The Post-Antibiotic Era: A New Dawn for Bacteriophages Jin, Youshun Li, Wei Zhang, Huaiyu Ba, Xuli Li, Zhaocai Zhou, Jizhang Biology (Basel) Review SIMPLE SUMMARY: Phages, also known as bacteriophages, are bacteria-specific viruses that are ushering in a new dawn following the increase in antibiotic resistance. In nature, phages are distributed wherever bacteria exist. They are divided into lytic and lysogenic phages based on their reproduction. Specifically, lysogenic phages reproduce within the bacteria as genetic elements, while lytic phages directly lyse bacteria to release progeny phages. Therefore, lytic phages can be used to treat bacterial infections. However, because the current phage therapy (PT) system has not yet been streamlined, there are still a series of PT-related concerns, such as phage isolation and purification efficiency, the immune response induced by PT, and the impact on intestinal microorganisms. Therefore, synthetic biology, bioinformatics, and artificial intelligence should be combined to edit high-efficiency directionally engineered phages that are safe for humans while effectively killing drug-resistant bacteria. ABSTRACT: Phages are the most biologically diverse entities in the biosphere, infecting specific bacteria. Lytic phages quickly kill bacteria, while lysogenic phages integrate their genomes into bacteria and reproduce within the bacteria, participating in the evolution of natural populations. Thus, lytic phages are used to treat bacterial infections. However, due to the huge virus invasion, bacteria have also evolved a special immune mechanism (CRISPR-Cas systems, discovered in 1987). Therefore, it is necessary to develop phage cocktails and synthetic biology methods to infect bacteria, especially against multidrug-resistant bacteria infections, which are a major global threat. This review outlines the discovery and classification of phages and the associated achievements in the past century. The main applications of phages, including synthetic biology and PT, are also discussed, in addition to the effects of PT on immunity, intestinal microbes, and potential safety concerns. In the future, combining bioinformatics, synthetic biology, and classic phage research will be the way to deepen our understanding of phages. Overall, whether phages are an important element of the ecosystem or a carrier that mediates synthetic biology, they will greatly promote the progress of human society. MDPI 2023-05-04 /pmc/articles/PMC10215799/ /pubmed/37237494 http://dx.doi.org/10.3390/biology12050681 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jin, Youshun
Li, Wei
Zhang, Huaiyu
Ba, Xuli
Li, Zhaocai
Zhou, Jizhang
The Post-Antibiotic Era: A New Dawn for Bacteriophages
title The Post-Antibiotic Era: A New Dawn for Bacteriophages
title_full The Post-Antibiotic Era: A New Dawn for Bacteriophages
title_fullStr The Post-Antibiotic Era: A New Dawn for Bacteriophages
title_full_unstemmed The Post-Antibiotic Era: A New Dawn for Bacteriophages
title_short The Post-Antibiotic Era: A New Dawn for Bacteriophages
title_sort post-antibiotic era: a new dawn for bacteriophages
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215799/
https://www.ncbi.nlm.nih.gov/pubmed/37237494
http://dx.doi.org/10.3390/biology12050681
work_keys_str_mv AT jinyoushun thepostantibioticeraanewdawnforbacteriophages
AT liwei thepostantibioticeraanewdawnforbacteriophages
AT zhanghuaiyu thepostantibioticeraanewdawnforbacteriophages
AT baxuli thepostantibioticeraanewdawnforbacteriophages
AT lizhaocai thepostantibioticeraanewdawnforbacteriophages
AT zhoujizhang thepostantibioticeraanewdawnforbacteriophages
AT jinyoushun postantibioticeraanewdawnforbacteriophages
AT liwei postantibioticeraanewdawnforbacteriophages
AT zhanghuaiyu postantibioticeraanewdawnforbacteriophages
AT baxuli postantibioticeraanewdawnforbacteriophages
AT lizhaocai postantibioticeraanewdawnforbacteriophages
AT zhoujizhang postantibioticeraanewdawnforbacteriophages